Key result
Hypercontractile and hypocontractile HFpEF phenotypes are linked to ~56% higher major cardiovascular events risk than intermediate LV elastance.
Why the study?
HFpEF is a heterogeneous entity including different LV function phenotypes, and the value of resting LV elastance (force) using transthoracic echocardiography to identify these phenotypes was unknown.
Does resting left ventricular elastance measured by transthoracic echocardiography identify distinct phenotypes and prognostic risks in patients with HFpEF?
Observational (n=2,380)
Yes
Does resting left ventricular elastance measured by transthoracic echocardiography identify distinct phenotypes and prognostic risks in patients with HFpEF?
Resting left ventricular elastance measured by volumetric transthoracic echocardiography can identify distinct HFpEF phenotypes, with hypercontractile and hypocontractile states associated with a higher risk of major adverse cardiac events.
Answers are grounded in this paper and cite their sources.
May stratify HFpEF prognosis via resting LV elastance; hypothesis-generating and should not yet change practice.
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity including different phenotypes of near normal, normal, and supernormal left ventricular (LV) function. The aim of this study was to assess the value of resting LV elastance (also known as force) using transthoracic echocardiography to identify HFpEF phenotypes. METHODS: In a prospective, observational, multicenter study, 2,380 patients with HFpEF were recruited from July 2016 to May 2024. Systolic blood pressure (SBP) was measured. LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), LV ejection fraction, force (SBP/LVESV), stroke volume (SV), arterial elastance, ventricular-arterial coupling, and left atrial volume index were assessed. Global longitudinal strain was available in 1,164 patients (48.9%). Six hundred eighty patients finished follow-up with a composite endpoint of major adverse cardiac events (MACEs). Patients were divided into three groups: group 1, low force (<25th percentile, <3.24 mm Hg/mL); group 2, intermediate force (≥25th percentile and ≤75th percentile, 3.24-5.48 mm Hg/mL); and group 3, high force (>75th percentile, >5.48 mmHg/mL). RESULTS: The three groups showed a gradient with descending values (group 3 > group 2 > group 1) for SBP, LV ejection fraction, global longitudinal strain, arterial elastance, and ventricular-arterial coupling, with the opposite gradient (group 1 > group 2 > group 3) for LVEDV, LVESV, SV, and left atrial volume index values (P < .01 for all). After a median follow-up period of 16 months, 205 MACEs occurred in 138 patients. The cumulative MACE rate was lowest in group 2 (14.7% person-years) and higher in groups 1 (16.1% person-years) and 3 (22.9% person-years; log-rank P = .036). CONCLUSIONS: Patients with HFpEF present with different LV contractile phenotypes, easily identified with resting LV force and volumetric transthoracic echocardiography. The dominant hemodynamic feature of hypocontractile phenotype is a preload recruitment with larger LVEDV and normal SV, while the hypercontractile phenotype is characterized by a small left ventricle with reduced SV. The hypercontractile and hypocontractile phenotypes are associated with a higher risk for subsequent events.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) conducted an observational in Heart failure with preserved ejection fraction (HFpEF) (n=2,380). Resting left ventricular elastance (force) phenotypes vs. Intermediate force (3.24-5.48 mm Hg/mL) was evaluated on Composite of major adverse cardiac events (MACEs) (p=0.036). Resting LV elastance identified hypercontractile and hypocontractile HFpEF phenotypes, which had higher major cardiovascular events rates than the intermediate phenotype.
Synapse has enriched 10 related papers. Consider them for comparative context: